Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Triglyceride metabolism refers to the complex biochemical processes involved in the synthesis, storage, transport, and breakdown of triglycerides in the body. This pathway plays a crucial role in energy homeostasis and lipid regulation. ## Structure and Overview Triglycerides (also called triacylglycerols) are the main form of fat storage and energy transport in the body. They consist of three fatty acid molecules attached to a glycerol backbone[2][5]. The metabolism of triglycerides involves several interconnected pathways that occur in different tissues, primarily the liver, adipose tissue, and intestines[6]. ## Key Metabolic Processes ### Triglyceride Synthesis (Lipogenesis) Triglyceride synthesis occurs through several pathways: 1. **Kennedy Pathway (sn-glycerol-3-phosphate pathway)**: The predominant route in the liver, accounting for more than 90% of liver triglyceride production. This pathway uses glycerol-3-phosphate derived from glucose metabolism as the backbone for triglyceride formation[6]. 2. **Dihydroxyacetone Phosphate (DHAP) Pathway**: Another important pathway in liver and adipose tissue where DHAP from glycolysis is converted to glycerol, which then serves as a precursor for triglyceride synthesis[6][7]. 3. **Monoacylglycerol Pathway**: Primarily active in the intestines during dietary fat absorption[6]. When carbohydrates are abundant, the liver converts excess glucose into fatty acids through de novo lipogenesis (DNL). This process is regulated by transcription factors like SREBP1c (activated by insulin) and ChREBP (activated by glucose)[2]. ### Triglyceride Transport Triglycerides are transported in the bloodstream via lipoprotein particles: - **Chylomicrons**: Formed in intestinal cells after dietary fat digestion, these particles transport triglycerides from the intestine to peripheral tissues and the liver[3][5]. - **Very Low-Density Lipoproteins (VLDL)**: Produced by the liver to transport endogenously synthesized triglycerides to peripheral tissues[4][5]. During transport, enzymes called lipases cleave fatty acids from triglycerides, allowing tissues to take up these fatty acids for energy production or storage[5]. ### Triglyceride Breakdown (Lipolysis) Triglyceride breakdown occurs through: 1. **Digestion**: In the digestive system, pancreatic lipases hydrolyze dietary triglycerides into fatty acids and monoglycerides, which are then absorbed by intestinal cells[3][6]. 2. **Intracellular Lipolysis**: Within adipose tissue, hormone-sensitive lipase and adipose triglyceride lipase break down stored triglycerides into glycerol and fatty acids during fasting or increased energy demand[5][7]. 3. **Fatty Acid Oxidation (β-oxidation)**: Once released, fatty acids undergo β-oxidation in mitochondria to produce acetyl-CoA, which enters the Krebs cycle to generate ATP[3][7]. ## Regulation of Triglyceride Metabolism Triglyceride metabolism is tightly regulated by hormones and signaling pathways: ### Hormonal Regulation - **Insulin**: Promotes triglyceride synthesis and storage by stimulating glucose and fatty acid uptake in adipose tissue and liver while inhibiting lipolysis[4]. - **Glucagon**: Acts in opposition to insulin, stimulating lipolysis in adipose tissue and promoting fatty acid oxidation in the liver during fasting[4]. - **Thyroid Hormones**: Release triglycerides from fat tissue during fasting or starvation to provide energy[5]. ### Signaling Pathways - **AMP-activated Protein Kinase (AMPK) Pathway**: Activated during low energy states, AMPK stimulates fatty acid oxidation and inhibits lipogenesis to restore energy balance[4]. - **Transcriptional Regulation**: Factors like SREBP1c and ChREBP control the expression of genes involved in fatty acid and triglyceride synthesis[2]. ## Role in Disease Dysregulation of triglyceride metabolism is associated with various metabolic disorders: - **Hypertriglyceridemia**: Elevated blood triglyceride levels increase the risk of cardiovascular diseases, including heart attack and stroke[5]. - **Metabolic Syndrome**: A cluster of conditions including high triglycerides, high blood pressure, and insulin resistance[5]. - **Non-alcoholic Fatty Liver Disease (NAFLD)**: Excessive accumulation of triglycerides in the liver, which can progress to inflammation and fibrosis[2]. ## Clinical Significance Maintaining healthy triglyceride levels is important for overall metabolic health. Lifestyle interventions such as a balanced diet, regular physical activity, and weight management can help regulate triglyceride metabolism and reduce the risk of associated diseases[5].
The triglyceride metabolism pathway involves the synthesis (lipogenesis), transport, and breakdown (lipolysis) of triglycerides. Drugs targeting this pathway would typically act on specific enzymes (e.g., lipases, enzymes in de novo lipogenesis), transport proteins (e.g., components of lipoprotein particles), or regulatory molecules (e.g., insulin signaling components, transcriptional factors like SREBP1c, ChREBP, or AMPK) to modulate these processes. The overall goal is to regulate energy storage, utilization, and lipid balance in the body.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Triglyceride Metabolism Pathway.